Standout Papers

Efficacy and Tolerability of Pegloticase for the Treatment of Chronic Gout in Patients Refractory... 2011 2026 2016 2021 366
  1. Efficacy and Tolerability of Pegloticase for the Treatment of Chronic Gout in Patients Refractory to Conventional Treatment (2011)
    John S. Sundy, Herbert S. B. Baraf et al. JAMA
  2. Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial (2021)
    Bernard Combe, Alan Kivitz et al. Annals of the Rheumatic Diseases

Immediate Impact

6 from Science/Nature 63 standout
Sub-graph 1 of 22

Citing Papers

JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
Interferon- γ and infectious diseases: Lessons and prospects
2024 StandoutScience
2 intermediate papers

Works of Herbert S. B. Baraf being referenced

Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial
2021 Standout
Circulating Intercellular Adhesion Molecule-1 in Patients with Systemic Sclerosis
1993

Author Peers

Author Last Decade Papers Cites
Herbert S. B. Baraf 1056 826 279 631 44 1.9k
Nobuaki Yamanaka 467 704 99 522 64 2.5k
Raimund Pichler 603 1249 88 430 43 3.0k
Gloria R. Gallo 345 869 127 146 43 2.0k
Philippe Vanhille 456 940 83 219 51 2.3k
N. Lawrence Edwards 849 1386 47 908 77 2.5k
Allan L. Metzger 1402 231 58 606 49 2.9k
Jay Garg 1296 623 74 187 41 2.5k
Young Hee Rho 1036 346 76 218 48 2.5k
Jan R. Brentjens 306 987 108 214 94 2.3k
Jer-Yuarn Wu 628 183 699 297 43 2.4k

All Works

Loading papers...

Rankless by CCL
2026